COMBINED MODALITY TREATMENT WITH INTENSIFIED CHEMOTHERAPY AND DOSE-REDUCED INVOLVED FIELD RADIOTHERAPY IN PATIENTS WITH EARLY UNFAVOURABLE HODGKIN LYMPHOMA (HL): FINAL ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG) HD11 TRIAL

被引：0
|
作者：
Engert, A.
Borchmann, P.
Diehl, V. [1 ]
Goergen, H. [1 ]
Mueller, H. [1 ]
Mueller, R.
Eich, H.
Mueller-Hermelink, H. [2 ]
Herrmann, R. [3 ]
Markova, J. [4 ]
Ho, A. [5 ]
Hiddemann, W. [6 ]
Doerken, B. [7 ]
Greil, R. [8 ]
机构：
[1] Univ Hosp Cologne, CHSG, Cologne, Germany
[2] Univ Wurzburg, Dept Pathol, D-8700 Wurzburg, Germany
[3] Kantonsspital Basel, Basel, Switzerland
[4] Univ Hosp Prague, Prague, Czech Republic
[5] Heidelberg Univ, Med Clin V, Heidelberg, Germany
[6] Univ Hosp Grosshadern, Munich, Germany
[7] Charite, D-13353 Berlin, Germany
[8] Salzburg Univ, A-5020 Salzburg, Austria
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0410
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [1] Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin Lymphoma (HL): Final analysis of the German Hodgkin Study Group (GHSG) HD11 trial
    Borchmann, P.
    Diehl, V
    Goergen, H.
    Mueller, H.
    Mueller, R. P.
    Eich, H.
    Mueller-Hermelink, K.
    Herrmann, R.
    Markova, J.
    Ho, A.
    Hiddemann, W.
    Doerken, B.
    Greil, R.
    Engert, A.
    ONKOLOGIE, 2010, 33 : 125 - 125
  • [2] Combined Modality Treatment with Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavourable Hodgkin Lymphoma (HL): Final Analysis of the German Hodgkin Study Group (GHSG) HD11 Trial
    Borchmann, Peter
    Diehl, Volker
    Goergen, Helen
    Mueller, Horst
    Mueller, Rolf Peter
    Eich, Hans T.
    Mueller-Hermelink, Hans Konrad
    Herrmann, Richard
    Markova, Jana
    Ho, Anthony D.
    Hiddemann, Wolfgang
    Doerken, Bernd
    Greil, Richard
    Engert, Andreas
    BLOOD, 2009, 114 (22) : 299 - 300
  • [3] Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group (GHSG) Randomized HD11 Trial
    Eich, H. T.
    Mueller, R. P.
    Diehl, V.
    Goergen, H.
    Mueller-Hermelink, H.
    Schmidt, B.
    Grosu, A.
    Karstens, J.
    Willich, N.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S1 - S1
  • [4] Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial
    Eich, Hans Theodor
    Diehl, Volker
    Goergen, Helen
    Pabst, Thomas
    Markova, Jana
    Debus, Juergen
    Ho, Anthony
    Doerken, Bernd
    Rank, Andreas
    Grosu, Anca-Ligia
    Wiegel, Thomas
    Karstens, Johann Hinrich
    Greil, Richard
    Willich, Normann
    Schmidberger, Heinz
    Doehner, Hartmut
    Borchmann, Peter
    Mueller-Hermelink, Hans-Konrad
    Mueller, Rolf-Peter
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) : 4199 - 4206
  • [5] DOSE-ESCALATION WITH BEACOPP ESCALATED IS SUPERIOR TO ABVD IN THE COMBINED-MODALITY TREATMENT OF EARLY UNFAVORABLE HODGKIN LYMPHOMA (HL): FINAL ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG) HD14 TRIAL
    Borchmann, P.
    Diehl, V.
    Pluetschow, A.
    Von Tresckow, B.
    Markova, J.
    Hitz, F.
    Kra, Z.
    Greil, R.
    Topp, M. S.
    Villalobos, M.
    Zijlstra, J. M.
    Soekler, M.
    Fuchs, M.
    Engert, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 180 - 180
  • [6] Dose-Intensified Combined Modality Treatment with 2 Cycles of BEACOPP Escalated Followed by 2 Cycles of ABVD and Involved Field Radiotherapy (IF-RT) Is Superior to 4 Cycles of ABVD and IF-RT in Patients with Early Unfavourable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial
    Borchmann, Peter
    Engert, Andreas
    Pluetschow, Annette
    Fuchs, Michael
    Markova, Jana
    Lohri, Andreas
    Kral, Zdenek
    Greil, Richard
    Topp, Max
    Villalobos, Matthias
    Zijlstra, Jose
    Soekler, Martin
    Stein, Harald
    Eich, Hans Theodor
    Mueller, Rolf Peter
    Diehl, Volker
    BLOOD, 2008, 112 (11) : 143 - 143
  • [7] Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma - An analysis of the German Hodgkin's Study Group (GHSG)
    Eich, H. T.
    Engenhart-Cabillic, R.
    Hansemann, K.
    Lukas, P.
    Seegenschmiedt, H.
    Staar, S.
    Willich, N.
    Mueller, R. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S535 - S535
  • [8] TREATMENT OF PATIENTS WITH HODGKIN LYMPHOMA IN EARLY FAVOURABLE STAGES: FINAL ANALYSIS OF THE RANDOMIZED GERMAN HODGKIN STUDY GROUP (GHSG) TRIAL HD10
    Eich, H. T.
    Mueller, R. P.
    Pluetschow, A.
    Debus, J.
    Bamberg, M.
    Wilborn, K.
    Eble, M.
    Diehl, V.
    Engert, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S158 - S159
  • [9] Dose-Escalation with BEACOPP Escalated Is Superior to ABVD In the Combined-Modality Treatment of Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial
    Engert, Andreas
    Borchmann, Peter
    Pluetschow, Annette
    von Tresckow, Bastian
    Markova, Jana
    Hitz, Felicitas
    Kral, Zdenek
    Greil, Richard
    Topp, Max S.
    Villalobos, Matthias
    Zijlstra, Josee M.
    Soekler, Martin
    Stein, Harald
    Eich, Hans-Theodor
    Mueller, Rolf-Peter
    Fuchs, Michael
    Diehl, Volker
    BLOOD, 2010, 116 (21) : 336 - 336
  • [10] Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma:: An analysis of the German Hodgkin Study Group
    Eich, Hans Theodor
    Engenhart-Cabillic, Rita
    Hansemann, Katja
    Lukas, Peter
    Schneeweiss, Angelika
    Seegenschmiedt, Heinrich
    Skripnitchenko, Roman
    Staar, Susanne
    Willich, Normann
    Mueller, Rolf-Peter
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (05): : 1419 - 1424
12345